A collaboration between scientists at Rutgers and Scripps Research led to the discovery of a small molecule that may slow down or stop the progression of Parkinson’s disease, a neurodegenerative disorder with no cure that affects 1 million people in the United States. To read the full article.
Recent Posts
- Alzheimer’s Research Center Receives $1.5 Million to Launch Physician-Scientist Program.
- Report Finds Broad Adoption of AI in New Jersey – and Strong Support for Regulation.
- Knowing Your Family’s Surgical History Might Be Key to Preventing Emergency Gallbladder Surgery.
- Join NJACTS for a Special Populations Seminar on 2/17 at 1pm
- Professor’s Research Opens Up New Possibilities for Treating a Painful Gastrointestinal Disease.
Categories
- Community (2,435)
- Covid (996)
- CTO Events (6)
- News (3,083)
- Pilots (21)